Active surveillance for low-risk prostate cancer, which involves forgoing immediate treatment, has increased threefold since such "conservative" management was recommended by major guidelines in the ...

Overtreatment of men with prostate cancer and limited life expectancy (LE) has persisted in the era of active surveillance and worsened in some instances, according to a new study. “Overtreatment of ...

Clinicians must appropriately assess life expectancy and take steps to avoid prostate cancer overtreatment. Even in the active surveillance era, overtreatment persists among men with limited life ...

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators offers new evidence that dietary changes may help reduce cancer cell growth in patients undergoing active surveillance, ...

Please provide your email address to receive an email when new articles are posted on . A diet with reduced omega-6 and increased omega-3 fatty acids could slow progression of prostate cancer. The ...

Outranked only by skin cancer, prostate cancer is the second most common cancer in men in the U.S. Although one in every eight American men will be diagnosed with prostate cancer at some point, an ...

DEAR DR. ROACH: I am a 66-year-old white male who is active and relatively healthy. I have recently been diagnosed with prostate cancer. One blood test showed a PSA level of 13 ng/mL, and a second was ...

I survived anxiety. I survived fear. I survived grief. I survived the sadness. I now wake up each day with peace, joy, confidence, and expectation. And I live every moment with urgency. I’ve got stuff ...

Stage 1 prostate adenocarcinoma is localized, non-aggressive, and often detected through routine screenings like PSA tests and DREs. Diagnosis involves PSA levels, Gleason scores, and possibly ...

Prostate cancer is the most common solid malignancy among men in the United States. According to the American Cancer Society, an estimated 313,780 men nationwide will be diagnosed with the disease in ...